EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›GBLI

GBLI

Global Indemnity Group, LLC

Next earnings Aug 4, 2026 · consensus $0.73 EPS, $122M rev

Last earnings -2.6% on 2026-05-05

Buy
$25.05
▼ -0.12%
$25.05▼ -22.38%
over 1Y
L $24.67EODHDH $32.27
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-0.1%
1W+0.1%
1M-4.8%
3M-7.8%
YTD-10.6%
1Y-22.4%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Buy
Quality
C
Valuation
Overvalued
Filings
Watch
Buy
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 6 analysts
Sell

A-rated, debt-free E&S insurer trading at ~0.51x book — a one-time wildfire hit masks a cheap, capital-returning underwriter.

Price / book value $25.05 vs BVPS $48.96 · 2026-07-03 / FY2025

The read

The fundamentals carry the rating, but the price is rich (~47% above our fair-value estimate) — a quality-at-a-price call. The case rests on the business, not the entry; patient buyers may wait for a pullback.

The headline looks ugly — net income fell 41% to $25.3M and diluted EPS dropped 44% to $1.75 — but the MD&A pins the damage on a discrete event: $15.7M of net California Wildfire losses booked in January 2025. Ex-wildfires, management states net income would have been $37.3M ($2.59/share) and the calendar-year combined ratio 94.6% versus the reported 98.6%, meaning the core book still underwrites at a profit. Gross written premiums actually grew 2.3% to $398.9M and net investment income rose to $62.7M, so the franchise is intact, not deteriorating. AM Best reaffirmed an A (Excellent) financial strength rating in August 2025.

The value case is the balance sheet and price. Global Indemnity carries no debt, holds $1.4B of cash and investments (98% fixed-maturities/cash), and grew stockholders' equity to $706.6M. Book value per share is $48.96, yet the stock trades at $25.05 — roughly 0.51x book. For a clean-balance-sheet insurer that has returned $649.5M to shareholders since its 2003 IPO and paid $20M in distributions in 2025 (a ~5.6% distribution yield at this price), that is a wide margin of safety. On normalized ex-cat earnings the P/E is under 10x.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$678M$629M$528M$441M$450M
Gross profit—————
Operating income—————
Net income$29.4M-$850K$25.4M$43.2M$25.3M
Diluted EPS$1.97-$0.09$1.83$3.12$1.75
Net margin4.3%-0.1%4.8%9.8%5.6%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield6.9%
FCF yield—

Quality & risk

ROIC (est.)—
Free cash flow—
Total debt$0.00
Net cash$65.5M
Piotroski F-Score4/7

Capital returns

Buyback yield0.0%
Dividend yield (est.)5.5%
Shareholder yield5.5%
Shares Δ YoY+4.1%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Shareholder vote2026-06-16

    Annual meeting: shareholders ratified board slate and routine proposals

  2. 8-K Officer / director change2026-05-22

    Officer/director change plus Reg FD disclosure; leadership transition

  3. 8-K Earnings results2026-05-05

    Q1 2026: earnings rebound vs wildfire-hit Q1 2025; still zero debt

  4. 10-Q Quarterly report2026-05-05

    Q1 2026: earnings rebound vs wildfire-hit Q1 2025; still zero debt

  5. DEF 14A Proxy statement2026-04-29
  6. 8-K Officer / director change2026-03-20

    Board/officer change announced

  7. 8-K Earnings results2026-03-12

    Supplemental FY2025 financial disclosure filed

  8. 8-K Earnings results2026-03-10

    FY2025 EPS $1.75 down 44%; wildfires cut income, equity up, A rating held

  9. 10-K Annual report2026-03-10

    FY2025 EPS $1.75 down 44%; wildfires cut income, equity up, A rating held

Recent filings

all on EDGAR ↗
4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗3/APeriod ending 2026-05-182026-06-29open ↗8-KPeriod ending 2026-06-102026-06-16open ↗3Period ending 2026-05-182026-05-28open ↗DEFA14AFiling2026-05-22open ↗8-KPeriod ending 2026-05-182026-05-22open ↗

Quality score

C
ValueGrowthProfitHealthMom.
ValueA
GrowthF
ProfitabilityC-
Financial healthA-
MomentumF
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓P/E below 25

Fair value est.

$13.39

Overvalued -47% vs price

cheapfair valueexpensive

Modified Graham: EPS $1.75 × (8.5 + 1.5 × 0.0% growth) × 0.90 quality = 7.7× multiple. An estimate, not a price target.

24.6752-week30.15
Revenue
$450M
+2.0% YoY
Net margin
5.6%
ROE
3.6%
P/E
14.3

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$450M+2.0%
Net income$25.3M-41.4%
Diluted EPS$1.75-43.9%
Cash & equivalents$65.5M+285.3%
Total assets$1.72B-0.6%
Total liabilities$1.01B-2.7%
Stockholders' equity$707M+2.5%
L/E: 1.44x

Frequently asked

Is Global Indemnity Group, LLC (GBLI) a buy?
GBLI currently carries a Buy rating with 3/5 conviction, derived from its latest SEC filings. A-rated, debt-free E&S insurer trading at ~0.51x book — a one-time wildfire hit masks a cheap, capital-returning underwriter.
What is GBLI's fair value?
A Modified-Graham model based on GBLI's SEC fundamentals estimates a fair value of about $13.39. It is an estimate from reported earnings, not a price target.
Is GBLI overvalued or undervalued?
Against a Modified-Graham fair-value estimate, GBLI currently appears overvalued relative to its SEC-grounded earnings power.
What is Global Indemnity Group, LLC's quality score?
GBLI scores 58.28462853224168/100 (grade C) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001494904, latest 10-Q filed 2026-05-05) · EODHD · Proprietary analysis · as of 7/3/2026, 9:38:38 AM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-06-30
FOX SAUL A
Director
Award9.15K @ $26.01$238K
2026-06-30
Colucci Michele
Director
Award1.01K @ $26.01$26.2K
2026-06-30
Murgio Jason Colt
Director
Award2.88K @ $26.01$75.0K
2026-06-30
McGeehan Thomas
Director
Award4.57K @ $26.01$119K
2026-06-30
Lederman bruce r
Director
Award4.35K @ $26.01$113K
2026-06-30
Karlinsky Fred Evan
Director
Award3.42K @ $26.01$89.0K
2026-06-30
Gersch Seth
Director
Award6.10K @ $26.01$159K

Dividends

Quarterly
Yield (TTM)
5.6%
Annual / share
$1.40
Last ex-date
2026-06-18
Last amount
$0.35
ex 2026-06-18paid 2026-06-29$0.35
ex 2026-03-20paid 2026-03-30$0.35
ex 2025-12-22paid 2025-12-30$0.35
ex 2025-09-29paid 2025-10-06$0.35
ex 2025-06-20paid 2025-06-27$0.35
ex 2025-03-21paid 2025-03-28$0.35

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-05-05Miss -52.6% est▼ -2.65%8-K ↗
2026-03-12Miss -50.4% est▼ -1.89%8-K ↗
2026-03-10Miss -50.4% est▼ -0.17%8-K ↗
2025-10-30Beat +10.9% est▲ +1.74%8-K ↗
2025-08-06Miss -9.6% est▼ -2.57%8-K ↗
2025-05-07—▼ -4.59%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Relative Strength Alert For Global Indemnity GroupBullish
nasdaq.com· 2026-06-24
Global Indemnity declares $0.35 dividendBullish
seekingalpha.com· 2026-06-04
Global Indemnity Group, LLC Announces Appointment of Michele Colucci to the Board of DirectorsBullish
globenewswire.com· 2026-05-19
Global Indemnity Group Q1 Earnings Call HighlightsBullish
finance.yahoo.com· 2026-05-05
Global Indemnity Group Q4 Earnings Call HighlightsBullish
finance.yahoo.com· 2026-03-10
Global Indemnity (GBLI) Earnings Call TranscriptBullish
finance.yahoo.com· 2026-03-10

Vs tracked universe

compare →

1195 tracked peers · median

EDGAR Score58 vs 67
Revenue growth2.0% vs 7.6%
Net margin5.6% vs 10.0%
Return on equity3.6% vs 12.0%
P/E14.3 vs 26.2

News sentiment

EODHD · 4d
Neutral
-0.03
vs typical · 4 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.